论文部分内容阅读
为提高α干扰素的抗病毒疗效,我们于1997年1月~2001年3月,应用重组干扰素α1b(rIFNα1b,深圳科兴生物公司生产)治疗慢性乙型病毒性肝炎125例,并随访1年,探讨了血清HBV DNA水平与rIFNα-1b疗效的关系。1对象和方法1.1研究对象
In order to improve the anti-virus efficacy of interferon-alpha, 125 patients with chronic hepatitis B were treated with recombinant interferon α1b (rIFNα1b, Shenzhen Kexing Bio-Company) from January 1997 to March 2001 and followed up for 1 Year, to explore the relationship between serum HBV DNA level and the efficacy of rIFNα-1b. 1 objects and methods 1.1 research object